| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$36 |
PainChek Business Update
|
30 Jan 2026 9:07AM |
$0.270 |
$0.170 |
fallen by
37.04%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- PainChek has achieved FDA De Novo clearance, allowing it to sell in the US market.
- PainChek's business model includes SaaS agreements and a new reimbursed model for RTM.
- There is a strong pipeline across the UK, ANZ, and North America with $1.9M ARR under negotiation.
- PainChek has 115,000 contracted licenses as of December 2025.
- The company has introduced a new tiered activation agreement with pre-payment options.
- PainChek Adult app has become the only FDA-cleared medical device for pain assessment in the USA.
- PainChek is positioned to benefit from RTM reimbursement codes, with a $3.05Bn total addressable market.
- The PainChek business model offers high gross margins over 80%.
- The company has conducted 17 million pain assessments across 200,000 residents globally.
- PainChek's future plans include launching an RTM business model in the US by March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$255 |
Company Update
|
30 Jan 2026 9:07AM |
$1.040 |
$0.635 |
fallen by
38.94%
|
|
BOC - Price-sensitive ASX Announcement
Full Release
Key Points
- BCL initiated a selection process for a mining partner in Q1 2025.
- Grant Samuel managed the strategic partnering process.
- CMOC Group Limited was chosen as the preferred mining partner in December 2025.
- ABG, the majority shareholder, did not support the CMOC partnership.
- ABG prefers Lloyd Metals & Energy Ltd. for the Panguna Mine redevelopment.
- BCL and CMOC are negotiating with ABG to gain support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$16 |
Trading Halt
|
30 Jan 2026 9:06AM |
$0.800 |
$0.510 |
fallen by
36.25%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- OncoSil Medical Limited requested a trading halt.
- The halt is pending a capital raising announcement.
- The halt remains until the announcement or 3 February 2026.
- The company expects to announce before 3 February 2026.
- The request complies with ASX Listing Rule 17.1.
- The request was authorized by the Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:06AM |
$0.450 |
$0.285 |
fallen by
36.67%
|
|
CHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash flow for Q2 FY26 was $11.3 million.
- Receipts from customers during the quarter were $32.5 million.
- Operating expenses included $14.3 million for operating costs, $3.0 million for staff, and $2.9 million for administration.
- A $1.8 million accrual for unbudgeted insurance expenses was identified.
- CHL has no unused financing facilities at the end of the quarter.
- Cash balance at the end of the quarter was $23.2 million.
- Membership revenue growth was solid despite a decline in other revenue streams.
- The report was authorized by the Board of Directors of Camplify Holdings Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pentanet Limited (5GG) ORDINARY FULLY PAID |
Communication Services |
$10 |
Q2FY26 Appendix 4C
|
30 Jan 2026 9:05AM |
$0.033 |
$0.023 |
fallen by
30.30%
|
|
5GG - Price-sensitive ASX Announcement
Full Release
Key Points
- Pentanet Limited's report covers Q2FY26, ending December 2025.
- Net cash from operations was $710,000.
- Final payment made for 5G Spectrum license in 26 GHz band.
- Cash and cash equivalents at end of the period were $2,416,000.
- The report includes details on Pentanet's financing facilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pentanet Limited (5GG) ORDINARY FULLY PAID |
Communication Services |
$10 |
Q2FY26 Quarterly Activities Report
|
30 Jan 2026 9:05AM |
$0.033 |
$0.023 |
fallen by
30.30%
|
|
5GG - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated revenue increased 2% QoQ and 7% PcP to $6 million.
- Positive EBITDA of $0.4 million for the fifth consecutive quarter.
- Telecommunications revenue up 2% QoQ and 6% PcP to $5.4 million.
- 5G revenue increased by 11% QoQ and 330% PcP to $0.25 million.
- Gaming segment revenue up 3% QoQ and 7% PcP to $0.68 million.
- CloudGG ARPU increased 6% QoQ to $23.
- Net cash from operating activities improved 19% QoQ to $0.7 million.
- Implemented 'Nothing But Net' brand campaign to enhance market engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$30,758 |
Advance Notice - 2026 Half Year Results
|
30 Jan 2026 9:04AM |
$21.050 |
$22.900 |
risen by
8.79%
|
|
| AUB Group Limited (AUB) ORDINARY FULLY PAID |
Financials |
$3,327 |
Application for quotation of securities - AUB
|
30 Jan 2026 9:04AM |
$30.300 |
$25.470 |
fallen by
15.94%
|
|
| Range International Limited (RAN) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:04AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
RAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Re>Pal Indonesia posts record sales revenue and production.
- Indonesian Q4 2025 sales revenue was US$737k.
- Re>Pal delivered 921 tonnes of pallets despite a 20-day production halt.
- Q4 2025 saw a 28% gross margin.
- Group cash burn was a net inflow of US$28k.
- Company relocating factory and seeking additional funding for rental fleet.
- Sales pipeline for Q1 2026 indicates strong customer support.
- Considering growth opportunities in Indonesia and the Philippines.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$10 |
EVE Completes Initial Production of Libbo
|
30 Jan 2026 9:04AM |
$0.020 |
$0.030 |
risen by
50%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of initial production of Libbo™ oral dissolving film.
- Transition from development to commercial execution.
- Libbo™ targets erectile dysfunction with faster onset of action.
- Positioning for market entry through telehealth and pharmacy channels.
- Supports EVE’s strategy of commercializing innovative pharmaceutical solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Santa Fe Minerals Ltd (SFM) ORDINARY FULLY PAID |
Materials |
$46 |
Quarterly Activities and Cashflow Report
|
30 Jan 2026 9:03AM |
$0.330 |
$0.285 |
fallen by
13.64%
|
|
SFM - Price-sensitive ASX Announcement
Full Release
Key Points
- Agreement to acquire 80% of four gold projects in Côte d'Ivoire from WIA Gold Limited.
- Projects cover a total area of 3,449 square km.
- Planning of first drilling campaign at Satama Gold Project to start in February 2026.
- Continued work on Watson’s Well Vanadium project and Challa Gold project.
- Net operating cash outflow of $400,000 for the current quarter.
- Cash and cash equivalents at the end of the period: $1.398 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flexiroam Limited (FRX) ORDINARY FULLY PAID |
Communication Services |
$26 |
Q2 FY26 Update and Appendix 4C
|
30 Jan 2026 9:03AM |
$0.024 |
$0.017 |
fallen by
29.17%
|
|
FRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Second consecutive quarter of positive operating cash flow.
- Positive net current assets for the first time in over eight years.
- Record underlying EBITDA of $2.0 million for H1 FY26.
- Strong cash balance of $3.5 million as of 29 January 2026.
- Launch of AI-assisted Connectivity Platform, Flexiroam.ai.
- Partnerships with Generali Insurance Malaysia and Dialog Group.
- Plan to scale partnerships and leverage AI for growth.
- Focus on maintaining financial discipline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$17 |
Quarterly Activities and Cashflow Reports
|
30 Jan 2026 9:02AM |
$0.013 |
$0.009 |
fallen by
30.77%
|
|
AQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Alice Queen Limited is conducting a strategic assessment of its Horn Island project due to a significant increase in gold prices.
- The 2021 Scoping Study for Horn Island showed a Net Present Value of A$140 million based on a gold price of A$2,450/oz.
- Gold price has surged to approximately A$6,000/oz, potentially increasing the project's value substantially.
- The Scoping Study is being updated with new assumptions and is expected to be completed in the first half of 2026.
- Alice Queen maintains a portfolio of gold exploration projects in Fiji and Australia.
- The company raised funds through a placement of shares to assist with ongoing projects.
- Despite expecting negative operating cash flows, Alice Queen is exploring fundraising options to support its activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oakajee Corporation Limited (OKJ) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities and Cashflow Report
|
30 Jan 2026 9:02AM |
$0.083 |
$0.060 |
fallen by
27.71%
|
|
OKJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued exploration at Paynes Find project in Western Australia.
- Completed Aircore drilling identified a new gold mineralised shear zone.
- Negative cash flow from operating activities was $196,000.
- Cash and cash equivalents at quarter-end were $78,000.
- Investments in listed shares valued at $4.691 million could fund operations.
- No new fundraising activities initiated; confident in raising equity if needed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$16 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:01AM |
$0.135 |
$0.165 |
risen by
22.22%
|
|
JNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant increase in operational income to $896k for Q2 FY26.
- Truck conversion and charge station sales totaled $472k.
- Deferred revenue of $1,558m recorded.
- Delivery of 8th truck to Cement Australia and completion of 2 export orders to USA.
- Installation of new Janus Charge and Change Station in South Australia scheduled.
- 49% reduction in primary operating expenditures.
- Operational metrics include 591,073 kilometers driven and 1,578 tonnes of CO2 abated.
- Completion of outstanding audit requirements and resumption of trading.
- Ongoing funding initiatives including a $5 million equity investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsrose Mining Limited (KRM) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 9:00AM |
$0.044 |
$0.031 |
fallen by
29.55%
|
|
KRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities was A$1.9 million for the quarter.
- Exploration expenditure totaled A$1.77 million, primarily under the BHP Alliance.
- Cash balance as of 31 December 2025 was A$22.444 million.
- Significant projects include the Penikat Project in Finland and the Råna Project in Norway.
- BHP-funded Finnmark exploration focuses on identifying major exploration targets.
- Kingsrose aims to maintain sustainability and growth through exploration alliances and M&A opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$5 |
Notification of cessation of securities - VFX
|
30 Jan 2026 8:59AM |
$0.097 |
$0.055 |
fallen by
43.30%
|
|
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$40 |
Quarterly activities and cashflow report
|
30 Jan 2026 8:59AM |
$0.210 |
$0.335 |
risen by
59.52%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Hydrogen achieved sustained hydrogen generation from its pilot plant in South Australia.
- Alana Barlow appointed as the inaugural CEO of Sparc Hydrogen.
- Secured second and third patents for PWS reactor technology.
- First commercial sale of ecosparc® to an Asian coatings company.
- Collaborated with Dulux Australia on ecosparc® enhanced coatings.
- Received A$981k R&D tax refund for FY25.
- Cash balance of A$1.94M as of 31 December 2025.
- Net cash from operating activities was positive.
- No outstanding debt after repaying Rockford RDF Pty Ltd cash advance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$59 |
Appendix 4C & Quarterly Update
|
30 Jan 2026 8:58AM |
$0.084 |
$0.083 |
fallen by
1.19%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA lifted the clinical hold on NUZ-001, allowing advanced clinical trials.
- NUZ-001 included in HEALEY ALS Platform Trial as Regimen I.
- Received $4.35 million from Australian Government’s R&D Tax Incentive.
- Completion of GMP tablet registration batches for NUZ-001.
- Grant of Australian patent for NUZ-001 through May 2041.
- Strategic partnership with Elanco Animal Health strengthened.
- Executed a comprehensive funding package to support HEALEY ALS Trial.
- Expanded presence in US capital markets with OTCQB Venture Market listing.
- Engagement with ALS community through fundraising and events.
- Continued focus on clinical development and regulatory submissions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Entropy Neurodynamics Limited (ENP) ORDINARY FULLY PAID |
Health Care |
$54 |
Quarterly Activities Report and Appendix 4C
|
30 Jan 2026 8:57AM |
$0.031 |
$0.034 |
risen by
9.68%
|
|
ENP - Price-sensitive ASX Announcement
Full Release
Key Points
- World-first clinical trial milestone with TRP-8803 for Binge Eating Disorder.
- Successful first patient enrolment and dosing.
- $6.1 million placement completed for clinical development funding.
- $847,186 R&D Tax Incentive received, more expected.
- Company rebranding to Entropy Neurodynamics Limited.
- Focus on biomarker-driven neuropsychiatry and psychedelic therapies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,378 |
Change in substantial holding
|
30 Jan 2026 8:57AM |
$7.670 |
$4.060 |
fallen by
47.07%
|
|
| Yugo Metals Limited (YUG) ORDINARY FULLY PAID |
Materials |
$32 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:56AM |
$0.056 |
$0.091 |
risen by
62.50%
|
|
YUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Yugo Metals Limited provided a quarterly activities report for December 2025.
- The company completed four diamond drill holes at the Kovacevac Prospect, identifying silver-zinc-lead mineralisation.
- A $3.5 million placement was completed to support the drilling program.
- Yugo Metals received a $0.4 million VAT refund from Bosnia-Herzegovina.
- The company undertook a dual listing on the Frankfurt and Dusseldorf Stock Exchanges.
- Yugo Metals has interests in three exploration project areas in Bosnia and Herzegovina.
- Net cash inflow during the quarter was approximately $2.6 million.
- The company has a cash balance of approximately $3.2 million as of 31 December 2025.
- During the quarter, Yugo executed a two-tranche placement raising $3.5 million.
- Yugo Metals focuses on exploration activities and is committed to enhancing shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$16 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:56AM |
$0.015 |
$0.013 |
fallen by
16.67%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Overdraft facility with a limit of EUR 40,000, unsecured, with an interest rate of 5.65%.
- Cash and cash equivalents at quarter end are AUD 6,340,000.
- Total available funding at quarter end is AUD 6,405,000.
- Estimated quarters of funding available are 5.10 quarters.
- The report complies with ASX Listing Rule 19.11A.
- The statement gives a true and fair view of the matters disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:55AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
1CG - Price-sensitive ASX Announcement
Full Release
Key Points
- Negative cash flow of $(903,000) from operations for the quarter.
- Revenue surpassed $6 million, a 28% increase year-on-year.
- User acquisition costs reduced by 38%.
- Over 230,000 users by end of 2025, with strong growth into 2026.
- Successful release of Version 2 of Little Money cash advance product.
- Planned growth in product offerings with continued focus on increasing profitability in 2026.
- Quarterly cash flow report highlights seasonality in revenue and marketing expenditure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Besra Gold Inc (BEZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$48 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:54AM |
$0.077 |
$0.115 |
risen by
49.35%
|
|
BEZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Besra Gold Inc. reported no production and development activities for the December 2025 quarter.
- Payments for direct exploration expenditure during the December 2025 Quarter totaled $478k.
- Net cash used in operating activities was reported at $2.085 million for the current quarter.
- The company focused on restructuring operations to secure renewal of key mining licenses in Malaysia.
- An updated JORC Mineral Resource Estimate for the Bau Gold Project was released, showing 2.28 million ounces of gold.
- Significant organisational changes were made, including restructuring of Malaysian operations and new appointments in the board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
